Alzheimer's Disease Cooperative Study (ADCS)

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Alzheimer's Disease Cooperative Study (ADCS) sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 1 currently recruiting 9 completed top decile by trial count

Alzheimer's Disease Cooperative Study (ADCS): 10 sponsored US clinical trials, 1 recruiting.

Alzheimer's Disease Cooperative Study (ADCS) sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 9 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimers Disease, with 2 trials.

Top-decile sponsor footprint

Alzheimer's Disease Cooperative Study (ADCS) ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING Phase 2

A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

NCT06223360
COMPLETED NA

"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"

NCT05350410
COMPLETED Phase 2

Prazosin for Agitation in Alzheimer's Disease

NCT03710642
COMPLETED NA

Exercise in Adults With Mild Memory Problems

NCT02814526
COMPLETED Phase 2

Resveratrol for Alzheimer's Disease

NCT01504854
COMPLETED

Alzheimer's Disease Neuroimaging Initiative Grand Opportunity

NCT01078636
COMPLETED NA

Home-Based Assessment for Alzheimer Disease Prevention

NCT00546767
COMPLETED Phase 3

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

NCT00440050
COMPLETED

ADNI: Alzheimer's Disease Neuroimaging Initiative

NCT00106899
COMPLETED Phase 3

Valproate in Dementia (VALID)

NCT00071721

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 2

Therapeutic Areas

Alzheimers Disease 2
Dementia Prevention 1
Mild Cognitive Impairment 1
Dementia 1
Alzheimer Disease 1

What is open in the Alzheimer's Disease Cooperative Study (ADCS) pipeline

1 recruiting of 10 indexed (10% open); 9 completed (90%).

Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).

Top condition: Alzheimers Disease (2 trials), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Alzheimer's Disease Cooperative Study (ADCS): open-pipeline peers nationwide

Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.

Alzheimer's Disease Cooperative Study (ADCS) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30%40% Total trials Recruiting share Alzheimer's Disease Cooperative Study (ADCS)Adamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAbiomedAimmune TherapeuticsAltria Client ServicesAscension Health
Alzheimer's Disease Cooperative Study (ADCS) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Alzheimer's Disease Cooperative Study (ADCS) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 10% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Alzheimer's Disease Cooperative Study (ADCS) page

10 registered trials is a research-attention snapshot, not an endorsement of Alzheimer's Disease Cooperative Study (ADCS) or any single study.

  • 1 of Alzheimer's Disease Cooperative Study (ADCS)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Alzheimers Disease is the condition Alzheimer's Disease Cooperative Study (ADCS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimers Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Alzheimer's Disease Cooperative Study (ADCS) pipeline card: 10 registered trials from official public datasets.Report a data error.